TITLE

Editorial: Glucagon therapy in acute pancreatitis

PUB. DATE
December 1973
SOURCE
British Medical Journal;12/1/1973, Vol. 4 Issue 5891, p503
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108986

 

Related Articles

  • Glucagon Secretion in Acute and Chronic Pancreatitis. Donowitz, Mark; Hendler, Rosa; Spiro, Howard M.; Binder, Henry J.; Felig, Philip // Annals of Internal Medicine;Dec75, Vol. 83 Issue 6, p778 

    Examines the secretion of plasma pancreatic glucagon in patients with acute pancreatitis. Complications of pancreatitis; Concentration of glucagon in the patients; Evidence of impaired glucagon secretion in patients with chronic pancreatitis.

  • Smoke or Fire? Acute Pancreatitis and the Liraglutide Trials. Gale, Edwin A. M. // Diabetes Care;Jun2015, Vol. 38 Issue 6, p948 

    The article offers insights on two studies examining pancreatitis and incretin-based therapies published in this issue of the journal. Particular focus is given to the debate surrounding the link between acute pancreatitis and incretin-based drugs. Also mentioned are the possible shared effect...

  • Newer Diabetes Drugs May Be Harming Your Pancreas.  // Healthy Years;Sep2013, Vol. 10 Issue 9, p6 

    The article presents research on the association of type 2 diabetes drugs to pancreas abnormalities. Study shows increase in pancreas size and pancreas dysplasia among incretin-treated diabetics. Another research suggests double risk for hospitalization of patients under glucagon-like peptide 1...

  • GLP-1 based agents and acute pancreatitis. Gale, Edwin A. M. // BMJ: British Medical Journal;3/2/2013, Vol. 346 Issue 7897, p9 

    The article focuses on the Food and Drug Administration (FDA) safety database that carries a signal for acute pancreatitis with the antidiabetic drug exenatide glucagon-like peptide-1-based therapies (GLP-1). It mentions that GLP-1 based agents are there in market for more than two years and...

  • Pancreatitis.  // Pancreatitis (National Digestive Diseases Info Clearinghouse);2008, Vol. 08 Issue 1596, p1 

    The article offers information on the pancreatitis disease which is the inflammation of the pancreas. It discusses the functions of the pancreas wherein it releases the hormones insulin and glucagon into the bloodstream. It notes the symptoms, diagnosis and treatment of the disease as well as...

  • Acute Pancreatitis (Book).  // Annals of Internal Medicine;2/15/94, Vol. 120 Issue 4, p352 

    Reviews the book 'Acute Pancreatitis: Diagnosis and Therapy,' edited by Edward L. Bradley.

  • Acute Pancreatitis: Diagnosis and Therapy. Pitchumoni, C. S.; Zetterman, Rowen K. // American Journal of Gastroenterology;May1994, Vol. 89 Issue 5, p814 

    Reviews the book "Acute Pancreatitis: Diagnosis and Therapy," edited by E. L. Bradley.

  • Rosuvastatin.  // Reactions Weekly;6/30/2012, Issue 1408, p28 

    The article describes a case of acute pancreatitis induced by rosuvastatin therapy in an elderly patient.

  • Pancreatitis Associated With Incretin-Based Therapies. IYER, SHRIDHAR N.; TANENBERG, ROBERT J.; MENDEZ, CARLOS E.; WEST, R. LEE; DRAKE III, ALMOND J. // Diabetes Care;Apr20123, Vol. 36 Issue 4, pe49 

    The article reports on acute pancreatitis induced by incretin-based therapies such as glucagon-like peptide-1 agonists (GLP-1) and dipeptidyl peptidase-IV inhibitors (DPP-IV) for the treatment of type 2 diabetes. It relates that the U.S. Food and Drug Administration (FDA) has not given approval...

  • Balancing Benefits and Risks in Patients Receiving Incretin-Based Therapies: Focus on Cardiovascular and Pancreatic Side Effects. Haluzík, Martin; Mráz, Miloš; Svačina, Štěpán // Drug Safety;Dec2014, Vol. 37 Issue 12, p1003 

    Incretin-based therapies either increase endogenous levels of glucagon-like peptide-1 by prolonging its half-life (DPP-4 inhibitors) or directly stimulate its receptor (glucagon-like peptide-1 analogues; GLP-1 RA). They are currently widely used for the treatment of patients with type 2 diabetes...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics